Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS · Delayed Price · Currency is USD
0.0471
-0.0029 (-5.80%)
Dec 16, 2025, 10:00 AM EST
Enzon Pharmaceuticals Market Cap
Enzon Pharmaceuticals has a market cap or net worth of $3.82 million as of December 16, 2025. Its market cap has decreased by -39.41% in one year.
Market Cap
3.82M
Enterprise Value
4.64M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since January 16, 1990, Enzon Pharmaceuticals's market cap has decreased from 108.08M to 3.82M, a decrease of -96.46%. That is a compound annual growth rate of -8.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 3.82M | -67.01% |
| Dec 31, 2024 | 11.58M | 66.86% |
| Dec 29, 2023 | 6.94M | -62.07% |
| Dec 30, 2022 | 18.31M | -27.99% |
| Dec 31, 2021 | 25.42M | 37.89% |
| Dec 31, 2020 | 18.43M | 102.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 743.26M |
| Elite Pharmaceuticals | 537.17M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 368.73M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 298.52M |
| Nika Pharmaceuticals | 291.10M |